id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-E-0111-0009,FDA,FDA-2008-E-0111,"U.S. Patent and Trademark Office to IPSEN Biomeasure, Inc. - Letter with Enclosed Certificate of Extension",Other,LET-Letter,2010-07-30T04:00:00Z,2010,7,2010-07-30T04:00:00Z,,2013-08-11T01:36:15Z,,0,0,0900006480b23b34
FDA-2008-E-0111-0008,FDA,FDA-2008-E-0111,U.S. Patent and Trademark Office to IPSEN -Notice of Final Determination,Other,LET-Letter,2009-12-04T05:00:00Z,2009,12,,,2009-12-07T21:55:28Z,,0,0,0900006480a6348a
FDA-2008-E-0111-0007,FDA,FDA-2008-E-0111,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2009-06-04T04:00:00Z,2009,6,2009-06-04T04:00:00Z,,2009-06-04T14:12:33Z,,0,0,09000064809c4a17
FDA-2008-E-0111-0006,FDA,FDA-2008-E-0111,Determination of Regulatory Review Period for Purposes of Patent Extension; SOMATULINE DEPOT,Notice,N-Notice,2008-11-18T05:00:00Z,2008,11,2008-11-18T05:00:00Z,2009-01-17T04:59:59Z,2024-11-07T22:00:28Z,,1,0,09000064807b01d3
FDA-2008-E-0111-0003,FDA,FDA-2008-E-0111,FDA/CDER to USPTO,Other,LET-Letter,2008-10-24T04:00:00Z,2008,10,2008-10-24T04:00:00Z,,2008-10-24T12:25:30Z,,0,0,0900006480522a16
FDA-2008-E-0111-0004,FDA,FDA-2008-E-0111,USPTO to FDA/CDER - Letter,Other,LET-Letter,2008-10-24T04:00:00Z,2008,10,2008-10-24T04:00:00Z,,2008-10-24T12:25:32Z,,0,0,09000064806f939e
FDA-2008-E-0111-0005,FDA,FDA-2008-E-0111,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2008-10-24T04:00:00Z,2008,10,2008-10-24T04:00:00Z,,2008-10-24T12:25:33Z,,0,0,0900006480777015
FDA-2008-E-0111-0002,FDA,FDA-2008-E-0111,USPTO - Letter,Other,LET-Letter,2008-10-24T04:00:00Z,2008,10,2008-10-24T04:00:00Z,,2008-10-24T12:25:29Z,,0,0,09000064803aaf31
FDA-2008-E-0111-0001,FDA,FDA-2008-E-0111,"IPSEN Biomeasure, Inc. - Patent Term Extension Application",Other,APP-Application,2008-10-24T04:00:00Z,2008,10,2008-10-24T04:00:00Z,,2008-10-24T12:25:28Z,,0,0,09000064803aaf1c